A large exposure to Brucella melitensis in a diagnostic laboratory.

Authors:
Address: Department of Medical Microbiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia. jicsam@ummc.edu.my
Journal:


Publication:

abstract

BACKGROUND:

Brucella species are easily transmitted by aerosols and can be acquired in the laboratory.

AIM:

To report the management of a large exposure to Brucella melitensis that occurred over six days in a hospital diagnostic laboratory.

METHODS:

Fifty-one exposed staff were managed according to Centers for Disease Control and Prevention guidelines. A further 96 non-exposed laboratory staff were tested for seroprevalence. Testing was carried out using the Brucella sp. serum agglutination test.

FINDINGS:

Twenty-seven people had high-risk exposure and 24 had low-risk exposure. High-risk staff were offered post-exposure prophylaxis. Twelve (44.4%) agreed to this, of whom eight (66.7%) completed the course. Overall compliance with serological follow-up at baseline, 2, 4, 6 weeks and 8 months was 45.9%. Despite this poor compliance there were no clinical brucellosis cases and no seroconversion in the 47.1% of staff tested at 8 months. Brucella sp. seroprevalence among all staff tested was 3/147 (2.0%).

CONCLUSION:

Lack of experience with Brucella spp. and lack of policies for handling potentially hazardous organisms contributed to this prolonged exposure. As compliance with current recommendations may be poor, the optimum frequency of serological follow-up and target groups for prophylaxis should be reassessed. Laboratories in low- or non-endemic areas must prepare for potential isolation of Brucella spp. The impact of human brucellosis in Malaysia requires further study.

Copyright © 2011 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.



Related Articles
Final Report on Carcinogens Background Document for Formaldehyde.
Rep Carcinog Backgr Doc. 2010
Final Report on Carcinogens Background Document for Formaldehyde.
National Toxicology Program. Rep Carcinog Backgr Doc. 2010 Jan; (10-5981):i-512.
Review Review of clinical and laboratory features of human brucellosis.
Indian J Med Microbiol. 2007
Review Review of clinical and laboratory features of human brucellosis.
Mantur BG, Amarnath SK, Shinde RS. Indian J Med Microbiol. 2007 Jul; 25(3):188-202.
Brucella spp. infection in large ruminants in an endemic area of Egypt: cross-sectional study investigating seroprevalence, risk factors and livestock owner's knowledge, attitudes and practices (KAPs).
BMC Public Health. 2011
Brucella spp. infection in large ruminants in an endemic area of Egypt: cross-sectional study investigating seroprevalence, risk factors and livestock owner's knowledge, attitudes and practices (KAPs).
Holt HR, Eltholth MM, Hegazy YM, El-Tras WF, Tayel AA, Guitian J. BMC Public Health. 2011 May 19; 11:341. Epub 2011 May 19.
Final Report on Carcinogens Background Document for Styrene.
Rep Carcinog Backgr Doc. 2008
Final Report on Carcinogens Background Document for Styrene.
National Toxicology Program. Rep Carcinog Backgr Doc. 2008 Sep; (8-5978):i-398.
Review Laboratory-based diagnosis of brucellosis--a review of the literature. Part I: Techniques for direct detection and identification of Brucella spp.
Clin Lab. 2003
Review Laboratory-based diagnosis of brucellosis--a review of the literature. Part I: Techniques for direct detection and identification of Brucella spp.
Al Dahouk S, Tomaso H, Nöckler K, Neubauer H, Frangoulidis D. Clin Lab. 2003; 49(9-10):487-505.

To top Home


Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.